{"id":"NCT01315249","sponsor":"Novartis Pharmaceuticals","briefTitle":"QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A 26-week Treatment, Multi-center, Randomized, Doubleblind, Double Dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2012-03","completion":"2012-03","firstPosted":"2011-03-15","resultsPosted":"2013-08-09","lastUpdate":"2013-08-09"},"enrollment":523,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"indacaterol and glycopyrronium (QVA149)","otherNames":[]},{"type":"DRUG","name":"Placebo to fluticasone/salmeterol","otherNames":[]},{"type":"DRUG","name":"fluticasone/salmeterol","otherNames":[]},{"type":"DRUG","name":"Placebo to indacaterol and glycopyrronium (QVA149)","otherNames":[]}],"arms":[{"label":"QVA149","type":"EXPERIMENTAL"},{"label":"fluticasone/salmeterol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety/tolerability of indacaterol and glycopyrronium (QVA149) (fixed-dose combination) with fluticasone/salmeterol over a 26-week period in patients with moderate to severe COPD.","primaryOutcome":{"measure":"Forced Expiratory Volume in 1 Second Area Under the Curve (FEV1 AUC) 0-12","timeFrame":"Week 26","effectByArm":[{"arm":"QVA149","deltaMin":1.69,"sd":0.027},{"arm":"Fluticasone/Salmeterol","deltaMin":1.56,"sd":0.026}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":93,"countries":["Belgium","Czechia","Estonia","Germany","Hungary","Lithuania","Norway","South Korea","Spain"]},"refs":{"pmids":["24321804"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":258},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis"]}}